129 related articles for article (PubMed ID: 20813214)
1. Proteasome and oxidative phoshorylation changes may explain why aging is a risk factor for neurodegenerative disorders.
Zabel C; Nguyen HP; Hin SC; Hartl D; Mao L; Klose J
J Proteomics; 2010 Oct; 73(11):2230-8. PubMed ID: 20813214
[TBL] [Abstract][Full Text] [Related]
2. Protein repertoire impact of Ubiquitin-Proteasome System impairment: insight into the protective role of beta-estradiol.
D'Alessandro A; D'Aguanno S; Cencioni MT; Pieroni L; Diamantini A; Battistini L; Longone P; Spalloni A; De Laurenzi V; Bernardini S; Federici G; Urbani A
J Proteomics; 2012 Feb; 75(4):1440-53. PubMed ID: 22146475
[TBL] [Abstract][Full Text] [Related]
3. Role of the proteasome in fly models of neurodegeneration.
Yeh CH; Jansen M; Schmidt-Glenewinkel T
Methods Mol Biol; 2011; 793():149-65. PubMed ID: 21913099
[TBL] [Abstract][Full Text] [Related]
4. Redox proteomics and the dynamic molecular landscape of the aging brain.
Perluigi M; Swomley AM; Butterfield DA
Ageing Res Rev; 2014 Jan; 13():75-89. PubMed ID: 24374232
[TBL] [Abstract][Full Text] [Related]
5. Oxidation and ubiquitination in neurodegeneration.
Riederer BM; Leuba G; Elhajj Z
Exp Biol Med (Maywood); 2013 May; 238(5):519-24. PubMed ID: 23856903
[TBL] [Abstract][Full Text] [Related]
6. Does impairment of the ubiquitin-proteasome system or the autophagy-lysosome pathway predispose individuals to neurodegenerative disorders such as Parkinson's disease?
Matsuda N; Tanaka K
J Alzheimers Dis; 2010; 19(1):1-9. PubMed ID: 20061621
[TBL] [Abstract][Full Text] [Related]
7. The ubiquitin-proteasome pathway in Parkinson's disease and other neurodegenerative diseases.
Ross CA; Pickart CM
Trends Cell Biol; 2004 Dec; 14(12):703-11. PubMed ID: 15564047
[TBL] [Abstract][Full Text] [Related]
8. Proteomic analysis of the human brain in Huntington's Disease indicates pathogenesis by molecular processes linked to other neurodegenerative diseases and to type-2 diabetes.
Schönberger SJ; Jezdic D; Faull RL; Cooper GJ
J Huntingtons Dis; 2013; 2(1):89-99. PubMed ID: 25063432
[TBL] [Abstract][Full Text] [Related]
9. The ubiquitin proteasome system in neurodegenerative diseases: culprit, accomplice or victim?
Dennissen FJ; Kholod N; van Leeuwen FW
Prog Neurobiol; 2012 Feb; 96(2):190-207. PubMed ID: 22270043
[TBL] [Abstract][Full Text] [Related]
10. Proteasome activation delays aging and protects against proteotoxicity in neurodegenerative disease.
Gonos E
Adv Exp Med Biol; 2015; 821():7. PubMed ID: 25416104
[No Abstract] [Full Text] [Related]
11. Precise assembly and regulation of 26S proteasome and correlation between proteasome dysfunction and neurodegenerative diseases.
Im E; Chung KC
BMB Rep; 2016 Sep; 49(9):459-73. PubMed ID: 27312603
[TBL] [Abstract][Full Text] [Related]
12. Comparative proteomics in neurodegenerative and non-neurodegenerative diseases suggest nodal point proteins in regulatory networking.
Zabel C; Sagi D; Kaindl AM; Steireif N; Kläre Y; Mao L; Peters H; Wacker MA; Kleene R; Klose J
J Proteome Res; 2006 Aug; 5(8):1948-58. PubMed ID: 16889417
[TBL] [Abstract][Full Text] [Related]
13. Age-related neurodegenerative disease associated pathways identified in retinal and vitreous proteome from human glaucoma eyes.
Mirzaei M; Gupta VB; Chick JM; Greco TM; Wu Y; Chitranshi N; Wall RV; Hone E; Deng L; Dheer Y; Abbasi M; Rezaeian M; Braidy N; You Y; Salekdeh GH; Haynes PA; Molloy MP; Martins R; Cristea IM; Gygi SP; Graham SL; Gupta VK
Sci Rep; 2017 Oct; 7(1):12685. PubMed ID: 28978942
[TBL] [Abstract][Full Text] [Related]
14. Aging in mouse brain is a cell/tissue-level phenomenon exacerbated by proteasome loss.
Mao L; Römer I; Nebrich G; Klein O; Koppelstätter A; Hin SC; Hartl D; Zabel C
J Proteome Res; 2010 Jul; 9(7):3551-60. PubMed ID: 20469937
[TBL] [Abstract][Full Text] [Related]
15. Quantitative expression proteomics and phosphoproteomics profile of brain from PINK1 knockout mice: insights into mechanisms of familial Parkinson's disease.
Triplett JC; Zhang Z; Sultana R; Cai J; Klein JB; Büeler H; Butterfield DA
J Neurochem; 2015 Jun; 133(5):750-65. PubMed ID: 25626353
[TBL] [Abstract][Full Text] [Related]
16. The application of proteomics and genomics to the study of age-related neurodegeneration and neuroprotection.
Weinreb O; Drigues N; Sagi Y; Reznick AZ; Amit T; Youdim MB
Antioxid Redox Signal; 2007 Feb; 9(2):169-79. PubMed ID: 17115941
[TBL] [Abstract][Full Text] [Related]
17. Oxidative Stress and Protein Quality Control Systems in the Aged Canine Brain as a Model for Human Neurodegenerative Disorders.
Romanucci M; Della Salda L
Oxid Med Cell Longev; 2015; 2015():940131. PubMed ID: 26078824
[TBL] [Abstract][Full Text] [Related]
18. Protein oxidation and degradation during aging: role in skin aging and neurodegeneration.
Widmer R; Ziaja I; Grune T
Free Radic Res; 2006 Dec; 40(12):1259-68. PubMed ID: 17090415
[TBL] [Abstract][Full Text] [Related]
19. [Free radical processes in aging, neurodegenerative diseases and other pathological states].
Dubinina EE; Pustygina AV
Biomed Khim; 2007; 53(4):351-72. PubMed ID: 18035718
[TBL] [Abstract][Full Text] [Related]
20. [Neurodegenerative conformational disease and heat shock proteins].
Kong XC; Bao XQ; Liu GT
Yao Xue Xue Bao; 2010 Nov; 45(11):1333-8. PubMed ID: 21361031
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
